COGT Competitors & Alternatives
Compare Cogent Biosciences Inc with similar stocks in the same industry
Biotechnology
COGT
Main Stock$31.21
Tradestie Score
59
Market Cap
$1.97B
Revenue Growth
-1.0%
Analyst Upside
+78.8%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.27
|
$6.03B | - | 44 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.39
|
$6.02B | - | 52 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$145.04
|
$5.92B | - | 43 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.17
|
$5.80B | 19.3 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$311.50
|
$5.20B | 40.1 | 49 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$60.43
|
$4.94B | - | 38 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$60.59
|
$4.93B | - | 45 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$58.02
|
$4.84B | - | 61 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More COGT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry